Latest Kaiser Health News Stories
Do sales reps in the operating room lend helpful expertise or inflate already bloated costs? Depends on whom you ask.
In this episode of KHN’s “What the Health?” Mary Agnes Carey of Kaiser Health News, Margot Sanger-Katz of The New York Times, Alice Ollstein of Politico and Anna Edney of Bloomberg News discuss the impact of House Democratic leadership elections and their impact on health policy; as well as efforts by the Trump administration to address high drug prices and ensure the safety of medical devices. Plus, Julie Rovner interviews KHN’s Jay Hancock about the latest “Bill of the Month.”
Medicare limits payments for valve replacement via a catheter to hospitals with large numbers of heart procedures. But smaller facilities are crying foul.
A new study in JAMA Surgery finds that a large sample of published medical research failed to disclose details on the financial relationships between medical device makers and physicians. Changes in the disclosure process could close this loop.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Anna Edney of Bloomberg News, Alice Ollstein of Talking Points Memo and Rebecca Adams of CQ Roll Call talk about health care’s emergence as a possible voting issue in the coming midterm elections. Plus, Rovner interviews KHN’s Emmarie Huetteman about July’s “Bill of the Month”: a transgender woman’s “bait-and-switch” $92,000 surgical bill.
Millions of Americans undergo procedures each year requiring medical scopes, but there’s growing concern about the risk of infection from dirty devices. Be prepared to ask questions — and bail if you’re not satisfied with the answers.
Your health insurance might not cover items such as wheelchairs, walkers, crutches and braces, or you may have to deal with a supplier that has a contract with your insurer.
The ‘scary’ findings show a discouraging lack of progress in cleaning the devices, despite more vigorous efforts in the wake of deadly superbug outbreaks, experts say.
The Seattle jurist finds that Olympus Corp. failed to properly disclose evidence that it knew of concerns about cleaning problems with its redesigned medical scopes years before they hit the market and were linked to dozens of deaths. The company maintains the devices were not defective and intends to appeal.
The inspector general at Health and Human Services says defective pacemakers or defibrillators had to be replaced from 2005 through 2014, costing Medicare $1.5 billion.
Agency says a removable cap will lower the risk of antibiotic resistant infections but some experts see it as a modest step in curbing the sort of deadly outbreaks that occurred a few years ago.
To strengthen your core knowledge of health care policy, it helps to be a regular reader of Kaiser Health News. Here’s a pop quiz to gauge what you have learned.
In the first case of its kind in the U.S., the company was ordered to pay damages to the hospital where a patient died of an infection linked to a contaminated scope. But jurors also found the hospital negligent, and it was ordered to pay the patients’ family $1 million.
LivaNova plant in Germany is the likely source behind outbreak that has sickened more than 100 people since 2013.
The Seattle case, the first to reach trial in the U.S., offers possible glimpse into fate of some two dozen lawsuits against manufacturing giant Olympus, accused of failing to address scope contamination linked to numerous deaths. The company faults poor hospital cleaning practices.
The medical supply industry makes a particularly revelatory case study of the difficulties of untangling global trade.
A new study, though small, finds extensive damage to commonly used medical scopes that could trap dangerous bacteria. That raises concerns about the potential for more outbreaks.
The FDA and other agencies are loosening restrictions on hearing aid sales and opening the door to less expensive, over-the-counter products.
Lawyers who deposed top company officials in a civil case say they declined to answer questions about their failure to warn American hospitals of infection risks. Industry giant Olympus also is the subject of a criminal probe.
Small manufacturers are betting that disposable medical scopes will slash the risk of infection during procedures. Some doctors are skeptical of the cheaper models.